+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinal Vein Occlusion"

Retinal Vein Occlusion Market Report and Forecast 2024-2032 - Product Thumbnail Image

Retinal Vein Occlusion Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
The Retina and its Disorders - Product Thumbnail Image

The Retina and its Disorders

  • Book
  • April 2011
Loading Indicator

Retinal Vein Occlusion (RVO) is a condition in which the veins in the retina become blocked, leading to vision loss. It is the second most common cause of vision loss in the elderly, and is often caused by hypertension, diabetes, and other vascular diseases. Treatment for RVO includes laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments such as optical coherence tomography (OCT) and fundus photography are used to diagnose and monitor the condition. In the RVO market, companies such as Carl Zeiss Meditec, Topcon Corporation, Heidelberg Engineering, Optovue, and Nidek Co. Ltd. are involved in the development and manufacture of optical imaging systems and treatments for RVO. These companies provide a range of products and services, including OCT systems, fundus cameras, laser photocoagulation systems, and intravitreal injections. Show Less Read more